![Douglas Reed](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Reed
Direttore/Membro del Consiglio presso
Viamet Pharmaceuticals Corp.
Profilo
Douglas W.
Reed currently works at Innocrin Pharmaceuticals Holdings LLC, as Chairman from 2014, Viamet Pharmaceuticals, Inc., as Director from 2007, Contego Medical, Inc., as Director, Viamet Pharmaceuticals Corp., as Director from 2011, Southeast BIO, as Director from 2009, Innocrin Pharmaceuticals, Inc., as Director, Standard Bariatrics, Inc., as Director, Qpex Biopharma, Inc., as Director, Hatteras Venture Affiliates III LP, as General Partner, and Hatteras Venture Partners, as General Partner from 2007.
Dr. Reed also formerly worked at Star Equity Holdings, Inc., as Director from 2000 to 2009, PhaseBio Pharmaceuticals, Inc., as Director, TetraLogic Pharmaceuticals Corp., as Independent Director from 2010 to 2016, SpineAlign Medical, Inc., as Director, BlinkBio, Inc., as Director, NeuroTronik, Inc., as Director, Sideris Pharmaceuticals, Inc., as Director, Gilead Connecticut, Inc., as Director from 2001 to 2010, Vector Asset Management, Inc., as Managing Director, Embrella Cardiovascular, Inc., as Director from 2009 to 2011, First National Bank of Crossett (Arkansas), as Director, NPS Pharmaceuticals, Inc., as Vice President-Business Development from 1996 to 1997, GelTex Pharmaceuticals, Inc., as Vice President-Business Development in 1999, GSK Equity Investments Ltd, as Principal, and the University of Washington, as Assistant Professor in 1983.
Dr. Reed received his undergraduate degree in 1977 and doctorate degree in 1978 from the University of Missouri-Kansas City and Masters Business Admin degree in 1989 from The Wharton School of the University of Pennsylvania.
Posizioni attive di Douglas Reed
| Società | Posizione | Inizio |
|---|---|---|
Qpex Biopharma, Inc.
 Qpex Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery, development and regulatory services for clinical-stage biopharmaceutical company | Direttore/Membro del Consiglio | - |
Innocrin Pharmaceuticals Holdings LLC
 Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Discovers and develops oral inhibitors for the treatment of castration-resistant prostate cancer | Presidente | 01/01/2014 |
Innocrin Pharmaceuticals, Inc.
 Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral inhibitors for the treatment of castration-resistant prostate cancer | Direttore/Membro del Consiglio | - |
Contego Medical, Inc.
 Contego Medical, Inc. Medical SpecialtiesHealth Technology Manufactures carotid and angioplasty systems | Direttore/Membro del Consiglio | - |
Southeast BIO | Direttore/Membro del Consiglio | 01/01/2009 |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Direttore/Membro del Consiglio | 01/05/2007 |
Hatteras Venture Affiliates III LP
 Hatteras Venture Affiliates III LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | - |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Direttore/Membro del Consiglio | 01/12/2011 |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Investitore di Private Equity | 01/01/2007 |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Precedenti posizioni note di Douglas Reed
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Douglas Reed
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
75
Relazioni di 1° grado
27
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 27 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatments of rare diseases | Health Technology |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Star Operating Cos., Inc.
 Star Operating Cos., Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures diagnostic imaging solutions, gamma cameras and construction | Health Technology |
PhaseBio Pharmaceuticals, Inc.
 PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Health Technology |
TetraLogic Pharmaceuticals Corp.
 TetraLogic Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases | Health Technology |
Hatteras Venture Affiliates III LP
Hatteras Venture Affiliates III LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
SpineAlign Medical, Inc.
 SpineAlign Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which develops implantable products to treat vertebral compression fractures | Health Technology |
Contego Medical, Inc.
Contego Medical, Inc. Medical SpecialtiesHealth Technology Manufactures carotid and angioplasty systems | Health Technology |
BlinkBio, Inc.
 BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology Develops orally active drugs that act like small drug molecules | Health Technology |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Health Technology |
NeuroTronik, Inc.
 NeuroTronik, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Sideris Pharmaceuticals, Inc.
 Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on development of therapeutics for the treatment of transfusion-related iron overload | Health Technology |
Innocrin Pharmaceuticals Holdings LLC
Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Discovers and develops oral inhibitors for the treatment of castration-resistant prostate cancer | Health Technology |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and biotechnology chemicals | Health Technology |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Finance |
Southeast BIO | |
Vector Asset Management, Inc.
 Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management invests in later-stage private and public companies in the life sciences and healthcare industries. Specific areas of interest include: biotechnology, pharmaceuticals, medical devices, diagnostics, plant and animal sciences, healthcare services, healthcare information technology and consumer applications of emerging healthcare technologies. They focus on companies that are raising capital in the private markets prior to the point at which they can access the public markets or execute an alternative exit strategy. Vector looks for companies ready to move from development stage to commercially viable operating entities in a relatively short time. The firm also participates in equity transactions involving securities of small- to mid-cap public companies in the life sciences and healthcare area. Most of Vector's investments are negotiated directly with company management. Vector is an active investor and generally leads or co-leads their investments. They usually serve on the Board of Directors of their portfolio companies. Investments range from $5 million to $15 million with an investment horizon of one to three years. | Finance |
Embrella Cardiovascular, Inc.
 Embrella Cardiovascular, Inc. Miscellaneous Commercial ServicesCommercial Services Develops proprietary systems for embolic cerebral protection during cardiovascular procedures | Commercial Services |
University of Missouri-Kansas City
 University of Missouri-Kansas City Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
First National Bank of Crossett (Arkansas)
 First National Bank of Crossett (Arkansas) Major BanksFinance Nationally chartered commercial bank | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral inhibitors for the treatment of castration-resistant prostate cancer | Health Technology |
Standard Bariatrics, Inc.
 Standard Bariatrics, Inc. Medical SpecialtiesHealth Technology Develops surgical instruments | Health Technology |
Qpex Biopharma, Inc.
Qpex Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery, development and regulatory services for clinical-stage biopharmaceutical company | Health Technology |
